By investigating the patient characteristics and concomitant drugs in Elderly-EO, we revealed that an IBD-type of CD, short disease duration, and no concomitant corticosteroid treatment are factors associated with the long-term efficacy of anti-TNF treatment for bio-naïve Elderly-EO patients. This evidence concerns the gene TNF and inflammatory bowel disease.